Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Geoffrey White

Urology Pinehurst, NC Medical Doctor

NPI 1376559443 CMS profile 402291

5 Firstvillage Drive, Pinehurst, NC 28374

Open in the dashboard

General payments

$4,078

154 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Geoffrey White of Pinehurst, NC is reported in the CMS Open Payments database as having received $4,078 across 154 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $156 8
2021 General $347 12
2020 General $1,095 60
2019 General $2,479 74

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Geoffrey White
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Geoffrey White were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Geoffrey White Urology median Middle half National median
2019 $2,479 $480 $147–$1,201 $163
2020 $1,095 $246 $87–$645 $114
2021 $347 $358 $111–$1,000 $132
2022 $156 $476 $143–$1,263 $149
2023 $0 $560 $168–$1,461 $160
2024 $0 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. NeoTract Inc. $1,591 19 payments
  2. Astellas Pharma US Inc $661 39 payments
  3. Dendreon Pharmaceuticals LLC $374 19 payments
  4. Endo Pharmaceuticals Inc. $301 24 payments
  5. AbbVie, Inc. $190 11 payments
  6. Boston Scientific Corporation $181 5 payments
  7. Teleflex LLC $152 2 payments
  8. DENTSPLY IH Inc. $107 7 payments
  9. Pfizer Inc. $93 7 payments
  10. Genzyme Corporation $86 1 payment
  11. Other $340 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $3,355 151 payments
  2. Travel and Lodging $660 1 payment
  3. Education $64 2 payments
Products named General payments · program years 2019–2022
  1. UROLIFT $1,591 19 payments
  2. XTANDI $376 30 payments
  3. PROVENGE $374 19 payments
  4. MYRBETRIQ $370 26 payments
  5. XIAFLEX $301 24 payments
  6. REZUM $159 4 payments
  7. UroLift System $152 2 payments
  8. LUPRON DEPOT $119 7 payments
  9. LoFric $107 7 payments
  10. AVEED $105 7 payments
  11. Other $638 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

154 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record